Orfadin oral suspension 4mg/ml ( DrugBank: - )
1 disease
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
241 | Hypertyrosinemia type I | 2 |
241. Hypertyrosinemia type I
Clinical trials : 14 / Drugs : 7 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 5
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|